Literature DB >> 2577280

Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise.

L Gullestad1, L O Dolva, S E Kjeldsen, I Eide, J Kjekshus.   

Abstract

The modifying effect on exercise performance and neuroendocrine response of the nonselective beta blocker timolol (10 mg b.i.d. for 5 days) and the beta 1-selective beta blocker metoprolol (100 mg b.i.d. for 5 days) was studied. The hormones studied were growth hormone, prolactin, cortisol, renin, epinephrine, dopamine, and norepinephrine. The response was studied during short-term maximal dynamic exercise, using two different exercise protocols; continuous (n = 11) and intermittent (n = 9) bicycle ergometry, in normal healthy young men. Accumulated work on placebo was nearly identical in the two studies, but was significantly reduced by 10.4% and 6.6% with timolol and by 4.7% and 6.7% with metoprolol, during continuous and intermittent exercise, respectively. During continuous exercise, accumulated work was 5.8% lower (p less than 0.05) with timolol than with metoprolol. The hormonal plasma concentrations of all hormones except renin were higher during continuous exercise than during intermittent exercise. Beta blockade had no effect on baseline hormonal levels, but the response was markedly changed during exercise. Maximum epinephrine, cortisol, and prolactin responses increased after beta blockade; dopamine remained nearly unchanged; while the renin responses were attenuated. Norepinephrine concentrations were slightly increased during continuous exercise by beta blockade and rose in direct proportion to the increase in workload. During intermittent exercise, maximum norepinephrine levels were significantly reduced by beta blockade compared with placebo. Thus the effect of beta 1-selective and nonselective beta receptor blockade on circulating hormones does not seem to explain the reduced exercise capacity following beta blockade.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2577280     DOI: 10.1007/bf01881530

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

1.  Radioimmunological determination of plasma renin activity during the menstrual cycle and during acute progesterone administration.

Authors:  J A Sundsfjord
Journal:  Acta Endocrinol (Copenh)       Date:  1971-05

2.  Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).

Authors:  J Erikssen; E Thaulow; R Mundal; P Opstad; S Nitter-Hauge
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.

Authors:  H Galbo; J J Holst; N J Christensen; J Hilsted
Journal:  J Appl Physiol       Date:  1976-06       Impact factor: 3.531

4.  Radioenzymatic determination of epinephrine, norepinephrine and dopamine in 0.1 ml plasma samples: plasma catecholamine response to submaximal and near maximal exercise.

Authors:  G Koch; U Johansson; E Arvidsson
Journal:  J Clin Chem Clin Biochem       Date:  1980-06

Review 5.  Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics.

Authors:  M Esler
Journal:  Clin Sci (Lond)       Date:  1982-03       Impact factor: 6.124

6.  Effect of beta-adrenoceptor blockade on exercise performance and metabolism.

Authors:  P Lundborg; H Aström; C Bengtsson; E Fellenius; H von Schenck; L Svensson; U Smith
Journal:  Clin Sci (Lond)       Date:  1981-09       Impact factor: 6.124

7.  Effects of propranolol and pindolol on plasma lignocaine clearance in man.

Authors:  T L Svendsen; M Tangø; S Waldorff; E Steiness; J Trap-Jensen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Beta-adrenoceptor blocking agents release catecholamines from rat adrenal medulla.

Authors:  K Sugawara; N Takami; S Maemura; M Niwa; M Ozaki
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

9.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.

Authors:  S E Kjeldsen; B Flaaten; I Eide; A Helgeland; P Leren
Journal:  Scand J Clin Lab Invest       Date:  1982-05       Impact factor: 1.713

View more
  2 in total

1.  Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.

Authors:  P K Rønnevik; J E Nordrehaug; G von der Lippe
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  The effect of acute exercise on interleukin-6 and hypothalamic-pituitary-adrenal axis responses in patients with coronary artery disease.

Authors:  Zeid Mahmood; Anette Davidsson; Eva Olsson; Per Leanderson; Anna K Lundberg; Lena Jonasson
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.